Conceptio › Archive › HAL (France)
HAL (France)open access

Regorafenib combined with irinotecan as second-line treatment in metastatic gastro-oesophageal adenocarcinomas: results of PRODIGE 58–UCGI35–REGIRI Unicancer randomised phase II study

E. Samalin et al.
HAL (France) · Papers · License: Open Access
Open Source ↗
0, 1, 2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 326314
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.